Roivant Sciences Eulerpool News

Roivant Sciences Aktie News

Roivant Sciences wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Roivant Sciences News stellen wir hier zusammen.

• 9. Juni ·

  Yahoo
  Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis
• 4. Juni ·

  SeekingAlpha
  Tourlite Capital Q1 2025 Investor Letter
• 29. Mai ·

  SeekingAlpha
  Roivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call Transcript
• 29. Mai ·

  Yahoo
  Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update
• 29. Mai ·

  SeekingAlpha
  Roivant Sciences Ltd. 2024 Q4 - Results - Earnings Call Presentation
• 23. April ·

  SeekingAlpha
  Roivant Sciences: Primed For Growth With A De-Risked Pipeline
• 21. April ·

  Yahoo
  Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug
• 21. April ·

  Yahoo
  Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift
• 21. April ·

  Yahoo
  Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
• 31. März ·

  SeekingAlpha
  Impax Small Cap Fund Q4 2024 Commentary